Logos Global Management LP Kinnate Biopharma Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.5 - $25.48 $1.56 Million - $2.4 Million	-94,345 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.81 - $24.87 $22 Million - $30.7 Million	-1,235,257 Reduced 92.9%	94,345 $2.17 Million
Q2 2021 Aug 16, 2021	BUY	$22.19 - $31.55 $8.77 Million - $12.5 Million	395,000 Added 42.26%	1,329,602 $31 Million
Q1 2021 May 17, 2021	BUY	$26.99 - $40.0 $9.85 Million - $14.6 Million	365,000 Added 64.08%	934,602 $29.1 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $20.7 Million - $25.8 Million	569,602 New	569,602 $22.7 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.